Intra-articular shoulder pathology including adhesive capsulitis, shoulder osteoarthritis and rotator cuff syndromes. Intra-articular shoulder injection. Ultrasound-guided injection. Modified anterior glenohumeral injection.
Conditions
Interventions
Insert the syringe needle 1 cm away from the outer edge of the coracoid bone, angling the needle 45 degrees downward (caudally). Insert the needle until it touches the bone and feels a 1-2 mm bounce-b
Experimental Procedure/Surgery,Placebo Comparator Procedure/Surgery
Modified anterior glenohumeral injection ,Ultrasound guided injection
Sponsors
Thammasat University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Individuals over the age of 18. 2. Individuals diagnosed with frozen shoulder (in the freezing stage) who have indications for steroid injection into the shoulder joint, specifically those who have not experienced improvement in pain after treatment with oral pain medication and physical therapy. 3. Individuals diagnosed with shoulder osteoarthritis (OA shoulder) who have indications for steroid injection into the shoulder joint, specifically those who have not experienced improvement in pain after treatment with oral pain medication and physical therapy. 4. Individuals diagnosed with rotator cuff syndrome (RC syndrome) who have indications for steroid injection into the shoulder joint, specifically those who have not experienced improvement in pain after treatment with oral pain medication and physical therapy.
Exclusion criteria
Exclusion criteria: 1. Patients diagnosed with a massive rotator cuff tear or complete rotator cuff tear based on physical examination and X-ray (disrupted gothic arc, AHI <7mm, superior humeral head migration), post-traumatic shoulder injury (previous fracture or dislocation around the shoulder, fracture of the clavicle, scapula, proximal humerus, or AC joint dislocation), history of shoulder arthroplasty (hemiarthroplasty, reverse total shoulder arthroplasty, and total shoulder arthroplasty). 2. History of receiving a steroid injection into the shoulder joint within the last 3 months. 3. History of allergy to steroid medication, lidocaine, or contrast agents.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy Within 20 minutes after injection Radio-opaque contrast injection checked with plain radiograph of the shoulder AP view | — |
Secondary
| Measure | Time frame |
|---|---|
| Range of motion Prior intervention, 1 month, 3 months and 6 months Degree ,Visual Analog Scale (VAS) for pain (0-10) Prior intervention, 5 mins, 1 month, 3 months and 6 months Visual Analog Scale (VAS) score for pain (0-10) ,Functional score Prior intervention, 1 month, 3 months and 6 months Oxford Shoulder Score ,Time to injection During intervention Seconds | — |
Countries
Thailand
Contacts
Public ContactKunaratt Chaichankul
Thammasat University Hospital
Outcome results
None listed